Chromatographic evidence for alternative pathways of TRH catabolism in the brain, involving either cleavage of the pGlu-His peptide bond or deamidation to form pGlu-HisPro (TRH-OH), has been described.In the present study, RIAs for TRH and TRH-OH were used to determine if synthetic TRH is degraded by rodent brain tissue into TRH-OH and to evaluate the relative rates of TRH and TRH-OH degradation and the concentrations of these two peptides in the brain.Incubation of the 27,000 X g supernatant of rodent brain tissue with synthetic TRH resulted in the formation of TRH-OH, which, under high TRH substrate conditions, was a function of the amount of brain tissue present. Treatment of normal rats and hamster with pharmacological doses of T 4 for 1 week did not significantly affect brain TRH deamidase activity. Under the in vitro conditions used, the rate of degradation of TRH was 487 ± 36 pg/min compared to 195 ± 31 pg/min for TRH-OH (P < 0.001). Despite the fact that TRH degradation was faster than TRH-OH degradation in the brain, the content of TRH-OH in regions of the brain was usually less than that of TRH and was often undetectable (<0.52 ng/extract). These data, while confirming the presence of a TRH deamidase in the brain, are compatible with the hypothesis that the percentage of TRH produced in the brain which undergoes deamidation in the brain in vivo is small. (Endocrinology 107: 443, 1980)